Oxygenta Pharmaceutical Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 33.51 | 37.02 | 49.79 |
| Operating Expense | 33.47 | 36.45 | 49.50 |
| Net Profit | -2.74 | -2.10 | -1.70 |
| Net Profit Margin | -8.18% | -5.67% | -3.41% |
| Earning Per Share | -0.74 | -0.57 | -0.45 |
| EBIDTA | 0.70 | 0.98 | -0.13 |
| Effective Tax Rate | 0% | 0% | 0% |
Particulars
Sep 2026
Revenue33.51
Operating Expense33.47
Net Profit-2.74
Net Profit Margin-8.18
Earning Per Share-0.74
EBIDTA0.70
Effective Tax Rate0
